← P22

Chapter 16 - Certain conditions originating in the perinatal period (P00-P96)»Respiratory and cardiovascular disorders specific to the perinatal period (P19-P29)»Respiratory distress of newborn, unspecified (P22.9)

P22.9

Respiratory distress of newborn, unspecified

Related indications (MeSH) (2)

Hyaline Membrane Disease7 drugs (6 approved, 1 experimental)

A respiratory distress syndrome in newborn infants, usually premature infants with insufficient PULMONARY SURFACTANTS. The disease is characterized by the formation of a HYALINE-like membrane lining the terminal respiratory airspaces (PULMONARY ALVEOLI) and subsequent collapse of the lung (PULMONARY ATELECTASIS).

Respiratory Distress Syndrome, Newborn26 drugs (18 approved, 8 experimental)

A condition of the newborn marked by DYSPNEA with CYANOSIS, heralded by such prodromal signs as dilatation of the alae nasi, expiratory grunt, and retraction of the suprasternal notch or costal margins, mostly frequently occurring in premature infants, children of diabetic mothers, and infants delivered by cesarean section, and sometimes with no apparent predisposing cause.